Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 9 of 9 Projects
Project # Contact PI Funding Organization Fiscal Year
Cognitive decline in early stages of AD after EGCG and a multimodal therapy
18PTC-R-592192 de la Torre, Rafael Alzheimer's Association 2018
ETHERAL : Epigenetic THERapy in ALzheimer’s Disease . A multicenter, multinational, randomized, double-blind, placebo-controlled, 3-arm, 26 weeks parallel-group study to evaluate the safety, tolerability of ORY-2001 in patients with mild-moderate AD
GC-201801-2014666 Bullock, Roger Alzheimer's Drug Discovery Foundation 2018
Sativex in MCI patients at high risk of developing AD
PTC C-16-422407 Ferrer, Isidro Alzheimer's Association 2016
Clinical development of a companion marker for treatment with the dual LSD1/MAO-B inhibitor ORY-2001
GC-2012832 Maes, Tamara Alzheimer's Drug Discovery Foundation 2016
GSK-3ß AND ADULT NEUROGENESIS. THERAPEUTIC POTENTIAL FOR AD.
2015-NIRG-340709  Llorens-Martín, María Alzheimer's Association 2015
Preclinical development of ORY-2001, a dual LSD1/MAOB inhibitor for the treatment of Alzheimer disease.
GC-2012231 Maes, Tamara Alzheimer's Drug Discovery Foundation 2015
Role of the endocannabinoid system in TDP43-related dementia
NIRP-12-258668 De Lago, Eva Alzheimer's Association 2013
Pharmacological manipulation of BDNF as therapeutic challenge for AD
NIRG-12-241889 Gil-bea, Francisco Alzheimer's Association 2012
First In Class Modifying Disease Drugs for Alzheimer's Disease
20100902 VEN-Maes-2010 Maes, Tamara Alzheimer's Drug Discovery Foundation 2010